Autoimmune gastritis causes LOW stomach acid and hides behind unexplained low iron for years. Symptoms, the antibody and gastrin blood panel, cancer surveillance, and what actually helps.
This site is an independent educational resource. This article is background reading, not medical advice. Autoimmune gastritis is a real diagnosis with cancer-surveillance implications, so work it up with a gastroenterologist, not a blog.
If you only do one thing: if you have unexplained low iron or B12, or iron-deficiency anemia that oral iron won't fix, ask a doctor about autoimmune gastritis and get the antibody and gastrin bloodwork. This condition hides behind a low ferritin for years, which is exactly what happened to Bryan Johnson.
Key takeaway
Autoimmune gastritis (AIG) is an immune attack on the acid-producing cells of your stomach. The counterintuitive part: it causes too *little* stomach acid, not too much, and it usually shows up first as stubborn iron deficiency, years before the classic B12/pernicious-anemia picture. It affects roughly 0.3 to 2.7% of people, it is diagnosed by antibodies plus endoscopy, and there is no supplement that reverses it. What management does is replace the iron and B12 you can no longer absorb and watch for the small but real stomach-cancer and tumor risk.
The surprising part: your gastrin runs high, not low
Here is the fact almost no one gets right. In autoimmune gastritis the immune system destroys the parietal cells that make stomach acid, so acid drops. But the stomach's antrum senses that missing acid and pumps out the hormone gastrin to try to fix it. That leaves you with high gastrin and low acid at the same time (Lahner 2009, PMID 19891010). That chronically high gastrin is not harmless: it relentlessly stimulates another cell type (ECL cells) in the stomach body, and over time that is what drives the type-1 neuroendocrine tumors AIG is known for (De Block 2004, PMID 15161793). The lab value people expect to be low is the one that is high, and it is the engine of the risk.
Why this is in the news: Bryan Johnson
In early July 2026, Bryan Johnson, the Blueprint founder and arguably the most-measured person alive, disclosed his own autoimmune gastritis: "my stomach is eating itself." His case is a textbook picture. He had a decade of low ferritin dismissed as "in range," pre-existing autoimmune thyroid disease (the classic pairing), and anti-parietal-cell antibodies at 103 units per milliliter against a normal ceiling near 20 (reported by MedPath, self-disclosed, not peer-reviewed). The lesson for everyone else: the clue sat in his own bloodwork for years, and "in range" is not the same as fine.
What autoimmune gastritis actually is
AIG is a chronic condition where antibodies attack the parietal cells lining the upper stomach (the corpus, or body, and fundus), destroying the cells that make both stomach acid and intrinsic factor, the protein you need to absorb vitamin B12 (Castellana 2024, *Cancers*, PMID 38610988). It is confined to the acid-producing part of the stomach and typically spares the antrum, which is one way it differs from the more common H. pylori type. Because it hits acid and B12 absorption, it quietly causes iron deficiency first and B12 deficiency later. It affects an estimated 0.3 to 2.7% of the general population.
Symptoms: why it hides for years
Direct answer: most people have no stomach symptoms at all, and the disease is usually found through a blood abnormality, not a stomachache.
- It is often silent. When there are symptoms, they are vague dyspepsia or reflux-type complaints, not a dramatic stomach problem (Castellana 2024, PMID 38610988).
- The first sign is usually iron deficiency, and the iron won't come up. AIG is an increasingly recognized cause of unexplained, oral-iron-refractory iron-deficiency anemia, because you need stomach acid to absorb non-heme iron (Hershko 2009, PMID 19786202). In one series, patients had a mean ferritin of 4 and needed IV iron, with B12 still normal (Goncalves 2014, PMID 25400463).
- B12 and the anemia come later. As intrinsic factor fails, B12 falls, eventually producing pernicious anemia with fatigue, weakness, and sometimes neurological symptoms (Lahner 2009, PMID 19891010). Pernicious anemia is the late stage of AIG, not a separate disease, and it can appear years or decades after the process starts.
- It is not just an "old person's" disease. About 15% of pernicious-anemia patients are young (Lahner 2009, PMID 19891010).
The "low stomach acid" twist
The wellness internet loves the phrase "low stomach acid symptoms" and sells acid supplements for it. AIG is the real version of low stomach acid, and it flips the usual advice on its head. You cannot fix destroyed parietal cells by swallowing acid, and here is the catch most people miss: even if you add acid with something like betaine HCl, you have not restored intrinsic factor, so your B12 absorption is still broken. There is no peer-reviewed evidence that betaine HCl treats autoimmune gastritis, and adding acid to an already-inflamed stomach can make symptoms worse. The move for real low-acid symptoms is testing, not an acid pill.
How autoimmune gastritis is diagnosed
Direct answer: a blood panel points to it, and an endoscopy with biopsy confirms it.
The blood test panel (what to ask for):
- Anti-parietal-cell and anti-intrinsic-factor antibodies. Combined, they run about 73% sensitivity and 100% specificity, so a positive intrinsic-factor antibody is very telling (Lahner 2009, PMID 19891010). Note that parietal-cell antibodies show up in some healthy people too, so antibodies alone are a clue, not a verdict.
- Serum gastrin (high) and pepsinogen I (low). This pattern is the serologic signature of damage to the acid-producing lining (Lahner 2009, PMID 19891010). The pepsinogen I to II ratio is the single best non-invasive marker, around 79% sensitivity and 90% specificity (Krike 2022, PMID 36428844).
- Ferritin, iron studies, and B12, since the deficiencies are often what surface first.
- An H. pylori test, because H. pylori is the other major cause of atrophic gastritis and should be found and treated if present (AGA, Shah 2021, PMID 34454714).
- Chromogranin A may be checked to gauge tumor-cell activity (De Block 2004, PMID 15161793), though it reads falsely high with acid-blocking PPI drugs and with kidney problems, so it is easy to misinterpret.
Confirmation: an upper endoscopy with biopsies from the stomach body, which is the only way to confirm the atrophy and stage it. As Bryan Johnson's case showed, the lining can look normal to the camera, so the biopsies are what make the diagnosis.
Autoimmune vs H. pylori gastritis
| Feature | Autoimmune gastritis | H. pylori gastritis |
|---|---|---|
| Cause | Immune attack on parietal cells | Bacterial infection |
| Location in stomach | Body/fundus (corpus), spares the antrum | Often antrum-predominant or patchy |
| Stomach acid | Low (acid cells destroyed) | Variable |
| Key antibodies | Anti-parietal-cell, anti-intrinsic-factor | None (test for the bacterium) |
| Fix the cause? | No cure; manage deficiencies + surveil | Yes, antibiotic eradication |
The two overlap in real life. Long-standing H. pylori may even help trigger the autoimmune process in some people, which is part of why testing for the bug matters (Lahner 2009, PMID 19891010). H. pylori is extraordinarily common, infecting an estimated 4.4 billion people worldwide (Hooi 2017, PMID 28456631).
Cancer and tumor risk: real, but keep it in proportion
Direct answer: AIG raises stomach-cancer risk several-fold, but the year-by-year absolute risk is low single digits, and the tumors it more commonly causes are usually slow-growing.
In autoimmune metaplastic atrophic gastritis, a meta-analysis put gastric cancer at about 0.14% per person-year (relative risk 11 versus the general population) and type-1 gastric neuroendocrine tumors at about 0.83% per person-year (Chen 2023, PMID 36769710). A narrative review reported higher figures (roughly 0.5% cancer and 2.8% neuroendocrine tumor per year), so the honest read is a range, with the pooled meta-analysis being the more conservative estimate (Castellana 2024, PMID 38610988). Pernicious anemia specifically carries a gastric-cancer relative risk around 2.84 (Song 2019, PMID 31048663). The type-1 neuroendocrine tumors are usually indolent and managed endoscopically, not the aggressive cancer people fear when they hear "tumor."
Surveillance: guidelines recommend a high-quality endoscopy roughly every 3 years for advanced atrophy (MAPS III, Dinis-Ribeiro 2025, PMID 40112834; AGA, Shah 2021, PMID 34454714), with closer follow-up (every 1 to 2 years) if neuroendocrine tumors are found and removed. This surveillance is the single most useful thing that happens after diagnosis.
The conditions that travel with it (thyrogastric and beyond)
AIG rarely comes alone. It clusters with other autoimmune disease, above all autoimmune thyroid disease, which is why Bryan Johnson's hypothyroidism plus gastritis is such a textbook pair. In pernicious-anemia cohorts, autoimmune thyroid disease shows up in around 40% and diabetes in about 10% (Lahner 2009, PMID 19891010). From the type-1 diabetes side, autoimmune gastritis runs about 5 to 10% and thyroid antibodies 20 to 25% (Kahaly 2016, PMID 26903475). Vitiligo and Addison's disease also co-travel. If you are diagnosed with one of these, the others are worth screening for, and the AGA specifically advises checking the thyroid (Shah 2021, PMID 34454714).
What actually helps (and what doesn't)
Direct answer: nothing regrows the acid cells, so management is replacing what you can no longer absorb, screening for the associated diseases, and surveillance. No supplement reverses the autoimmune process.
- Replace B12. High-dose oral B12 (around 1,000 to 2,000 micrograms a day) can work through a small acid-independent absorption route and may match injections for many people (Butler 2006, PMID 16585128), though the evidence base is thin and many clinicians still start injections in true pernicious anemia. Your doctor picks based on your levels and any neurological signs.
- Replace iron, often with IV iron, because oral iron frequently fails when stomach acid is gone (Hershko 2009, PMID 19786202).
- Screen for autoimmune thyroid disease and the other associated conditions (Shah 2021, PMID 34454714).
- Keep the surveillance endoscopy schedule. This is what catches the small tumor risk early.
- What supplements cannot do: there is no gut supplement, peptide, or acid pill shown to reverse AIG or restore intrinsic factor. Anything sold as a "cure" is not supported. The gut-lining supplements with real human data (covered in our gut healing supplements guide) are for the general gut, not for reversing this autoimmune process.
What to ask your doctor for
If you have unexplained low iron or B12, iron-deficiency anemia that oral iron won't fix, or a family history of pernicious anemia or autoimmune thyroid disease, this is the panel to discuss: ferritin and iron studies, B12, anti-parietal-cell and anti-intrinsic-factor antibodies, serum gastrin, pepsinogen I and the PGI/II ratio, an H. pylori stool or breath test, thyroid antibodies (TPO), and a referral for upper endoscopy with body biopsies. That workup, not a supplement stack, is what finds and stages the actual problem.
Key numbers at a glance
| Fact | Number | Source |
|---|---|---|
| Prevalence (general population) | 0.3-2.7% | PMID 38610988 |
| Anti-IF + anti-parietal-cell antibodies | 73% sensitivity, 100% specificity | PMID 19891010 |
| Pepsinogen I/II ratio (best single non-invasive marker) | ~79% sensitivity, 90% specificity | PMID 36428844 |
| Gastric cancer risk | ~0.14%/year, RR 11 (up to ~0.5% in some reviews) | PMID 36769710, 38610988 |
| Type-1 neuroendocrine tumor risk | ~0.83%/year, usually indolent | PMID 36769710 |
| Autoimmune thyroid disease overlap (PA cohorts) | ~40% | PMID 19891010 |
| Surveillance endoscopy (advanced atrophy) | ~every 3 years | PMID 40112834 |
Frequently asked
Weekly drops, weekly research
New guides, price-drop alerts, and reader-submitted protocols. One email a week. Unsubscribe anytime.
No spam. Unsubscribe anytime.

Discussion
Sign in to join the discussion
No comments yet โ be the first to share your thoughts!